Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.
Fidelity Advisor Health Care Fund - Class Z FIKCX
- NAV / 1-Day Return 72.33 / +0.17 %
- Total Assets 3.1B
-
Adj. Expense Ratio
0.560%
- Expense Ratio 0.560%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 52%
USD | NAV as of Aug 07, 2026 | 1-Day Return as of Aug 07, 2026, 12:11 AM GMT+0
Morningstar’s Analysis FIKCX
Will FIKCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 7.94 | 252M | Healthcare |
Danaher Corp | 6.51 | 207M | Healthcare |
Thermo Fisher Scientific Inc | 5.02 | 159M | Healthcare |
Johnson & Johnson | 4.56 | 145M | Healthcare |
UnitedHealth Group Inc | 3.88 | 123M | Healthcare |
AbbVie Inc | 2.70 | 86M | Healthcare |
Ascendis Pharma AS | 2.25 | 71M | Healthcare |
Alnylam Pharmaceuticals Inc | 1.97 | 63M | Healthcare |
Merck & Co Inc | 1.86 | 59M | Healthcare |
Gilead Sciences Inc | 1.75 | 56M | Healthcare |